Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05211726 · ClinicalTrials.gov registry record · NA

The Effects of Added Sugar Intake on Brain Blood Flow and Hippocampal Function in Midlife Adults

A NA study of Aging and Healthy Diet, sponsored by University of Delaware.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT05211726 is a NA study of Aging and Healthy Diet that has completed, run by University of Delaware. The registered enrollment target is 44 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05211726, a NA study of Aging and Healthy Diet, has completed, sponsored by University of Delaware.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

This study will focus on improving brain health through dietary modification of added sugars in middle aged adults (50- 64 years old). Participants will be fed two 10-day diets (one diet containing 5% of total energy from added sugars and one diet containing 25% of total energy from added sugars) and examine blood vessel function, hippocampus structure using a MRI, and memory performance.

Conditions Studied

Interventions

  • OTHER Low Added Sugar Diet
  • OTHER High Added Sugar Diet

Study Locations (1)

Delaware

  • University of Delaware - Newark

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2022-01-11
Est. Completion 2024-05-03
Phase NA

Sponsor

University of Delaware

106 total trials

What the Registry Record Tells You About NCT05211726

The ClinicalTrials.gov registry entry for NCT05211726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Low Added Sugar Diet is the first listed.

NCT05211726 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT05211726 about?

NCT05211726 is a clinical study titled "The Effects of Added Sugar Intake on Brain Blood Flow and Hippocampal Function in Midlife Adults". This study will focus on improving brain health through dietary modification of added sugars in middle aged adults (50- 64 years old). Participants will be fed two 10-day diets (one diet containing 5% of total energy from added sugars and one diet containing 25% of total energy from added sugars) an...

What is the current status of trial NCT05211726?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2022-01-11. Estimated completion is 2024-05-03.

What conditions does trial NCT05211726 study?

This clinical trial studies the following conditions: Aging, Healthy Diet.

What interventions are being tested in trial NCT05211726?

The interventions under investigation include: Low Added Sugar Diet (OTHER), High Added Sugar Diet (OTHER).

Who is sponsoring clinical trial NCT05211726?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05211726 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.